Antagonist of D1-like receptor inhibits cartilage destruction in a human RA/SCID mouse chimera model and this effect is associated with decrease of dopamine-mediated IL-6 and IL-17 (Nakano et al. 2011). The gene discussed is IL6; the disease is rheumatoid arthritis.